Biocon Limited: Q1 FY17 Earnings Call Transcript July 22, 2016 Participants from Biocon’s Senior Management Team Kiran Mazumdar Shaw: Chairperson and Managing Director Arun Chandravarkar: CEO & Jt. Managing Director

Source URL: www.biocon.com

• Biology
• Medicine
• Biotechnology
• Specialty drugs
• Peptide hormones
• Recombinant proteins
• Eli Lilly and Company
• Trastuzumab
• Kiran Mazumdar-Shaw
• Biosimilar
• Biocon
• Biopharmaceutical

Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20

Source URL: www.biocon.com

• Biotechnology
• Biology
• Medicine
• Recombinant proteins
• Specialty drugs
• Biosimilar
• Drugs
• Biopharmaceutical
• Trastuzumab
• Mylan
• Pegfilgrastim
• Filgrastim

Patientinformation – tillæg til DBCG 2015-b,t og 2015-d,t (Trastuzumab) Antistofbehandling af brystkræft efter operation Denne information supplerer vores mundtlige information om den behandling, vi anbefaler dig. I

Source URL: www.dbcg.dk

FINAL Press Release Biocon Reports a Strong Q1FY17 Revenues at Rs 952 Crore, up by 11 %; EBITDA Up 15% to Rs 271 Crore

Source URL: www.biocon.com

• Recombinant proteins
• Peptide hormones
• Generally Accepted Accounting Principles
• Biotechnology
• Eli Lilly and Company
• Insulin analog
• Biosimilar
• Biocon
• Trastuzumab
• Pharmaceutical industry in India
• Kiran Mazumdar-Shaw
• Biopharmaceutical

Investor Presentation June 2016 BSE: 532523 │ NSE: BIOCON │ REUTERS: BION.NS │ BLOOMBERG: BIOS IN │ WWW.BIOCON.COM

Source URL: www.biocon.com

• Peptide hormones
• Recombinant proteins
• Specialty drugs
• Biotechnology
• Monoclonal antibodies
• Trastuzumab
• Biocon
• Insulin glargine
• Insulin
• Biosimilar
• Pharmaceutical industry in India
• Biopharmaceutical

EDITORIAL STAFF From the Editor Debu Tripathy, MD Editor-in-Chief

Source URL: gotoper-com.s3.amazonaws.com

• Cancer treatments
• Oncology
• Antineoplastic drugs
• Ribbon symbolism
• Immunology
• Trastuzumab emtansine
• Trastuzumab
• Breast cancer
• Circulating tumor cell
• HER2/neu
• Metastatic breast cancer
• Chemotherapy

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 217 Pharmacometric Models for Antibody Drug Conjugates and Taxanes in HER2+ and HER2Breast Cancer

Source URL: uu.diva-portal.org

• Clinical medicine
• Medicine
• Cancer
• Cancer treatments
• Immunology
• Antineoplastic drugs
• Ribbon symbolism
• Biotechnology
• Trastuzumab emtansine
• Trastuzumab
• Antibody-drug conjugate
• Mertansine

Digital Unix 4.0 Upgrade Plan

Source URL: www.cgl.ucsf.edu

• Biology
• Molecular biology
• Biotechnology
• Nature
• Hoffmann-La Roche
• Genentech
• South San Francisco
• California
• Tissue plasminogen activator
• Recombinant DNA
• Polymerase chain reaction
• Growth hormone treatment
• Trastuzumab

若手研究者インターナショナル・トレーニング・プログラム(ITP) バイオインフォマティクスとシステムズバイオロジーの国際連携教育研究プログラム 応募書類 Name:

Source URL: www.bic.kyoto-u.ac.jp

• Medicine
• Clinical medicine
• Cancer
• Tyrosine kinase receptors
• Antineoplastic drugs
• Cancer treatments
• Oncology
• HER2/neu
• Phosphoinositide 3-kinase
• C-Met
• Trastuzumab
• Breast cancer

Microsoft PowerPoint - Vyberg-Belgium-0611

Source URL: www.nordiqc.org

• Medicine
• Histology
• Immunology
• Immunohistochemistry
• Staining
• Immunostaining
• Trastuzumab
• External quality assessment
• Fixation
• Anatomy
• Biology
• Protein methods